跳至主要内容
临床试验/ACTRN12605000167662
ACTRN12605000167662招募中1 期

A double blind randomised placebo-controlled intervention trial to determine the efficacy of the probiotic VSL #3 in reducing the incidence and or frequency of diarrhoea in enterally-fed critically ill patients.

Department of Health and Human Services (Tasmanian Government)0 个研究点目标入组 100 人开始时间: 2005年8月17日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • All prospective adult participants that may require tube feeding as part of their routine management of their illness while a patient admitted to the ICU will be screened preoperatively in the pre-admission clinic or on admission to the ICU.

排除标准

  • Patients with the following characteristics would be excluded from the study; < 18 years Likely to be tube fed < 48 hours Allergy to milk preparations Present with special dietary requirements (other than diabetic or renal considerations) requiring Total Parenteral Nutrition (TPN) Present with any condition that might interfere with the delivery of enteral feeds such as obstruction of the gastrointestinal tract.

研究者

发起方
Department of Health and Human Services (Tasmanian Government)

相似试验